<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Moore, Halle C.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Goserelin Improves Ovarian Function in Premenopausal Women with Estrogen Receptor-Negative/Progesterone Receptor-Negative Breast Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-20</style></pages><abstract><style  face="normal" font="default" size="100%">The addition of goserelin to standard chemotherapy treatment in premenopausal women with hormone receptor-negative breast cancer resulted in a reduced rate of ovarian dysfunction and a greater rate of successful pregnancies. This article presents data from the S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer trial [POEMS; NCT00068601; Moore HCF et al. J Clin Oncol 2014].</style></abstract><number><style face="normal" font="default" size="100%">14</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>